RESOURCES

your cart
  • Cart
  • Shipping
  • Confirmation

Thank you for your order. A confirmation
email will be sent to you shortly.

Please allow approximately 10 business days for your resources to arrive.

  • Cart
  • Shipping
  • Confirmation

Shipping Information *Required fields

Complete the fields below to receive your shipment.

Sign up for more information about EYLEA

I authorize Regeneron Pharmaceuticals, Inc., [the maker of EYLEA® (aflibercept) Injection,] together with its collaborators, affiliates, representatives, agents, and contractors (collectively, “Regeneron”), to provide me with educational and promotional information, materials, and services. Regeneron may de-identify information I provide and use it in performing research, education, business analytics, marketing studies, or for other commercial purposes. Additionally, I understand that Regeneron may use my information (1) to help improve, develop, and evaluate products, services, materials, and programs related to my condition and treatment; and (2) as otherwise described in the Regeneron Privacy Policy.

I also agree that Regeneron may contact me by mail or e-mail with information about [EYLEA, including its FDA-approved indications,] [diseases, treatments] and any related information.

Message and data rates may apply. I understand that I may opt out of these communications by e-mailing commercialanalytics@regeneron.com or by sending a letter to Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, Attention: Commercial Analytics.

By clicking “Place Order” below, I am signing this form and confirming that I have read, understand, and agree with the Regeneron Privacy Policy and Terms and Conditions.

By checking this box and clicking “Place Order” below, I further authorize Regeneron to contact me by phone or SMS/text message at the telephone number I have provided, which could result in messaging or data charges to me depending on my wireless service plan. I agree to notify Regeneron if my number changes in the future. I also authorize Regeneron to contact me using prerecorded/artificial voice messages or an automatic dialing system. I understand that these calls or messages may advertise or market Regeneron’s products, goods, or services. I do not need to agree to receive calls or SMS/text messages as a condition of purchasing any goods or services.

Your cart is
currently empty.

  • Cart
  • Shopping
  • Confirmation

Your Cart

The resources you selected are listed below. Please use the individual resource drop-down menu to select a quantity for shipment.

RESOURCES

Select A Quantity

See More Important Safety Information and Indications
  • CONTRAINDICATIONS: EYLEA® (aflibercept) Injection is contraindicated in patients with ocular or periocular infections, active intraocular inflammation, or known hypersensitivity to aflibercept or to any of the excipients in EYLEA.
Important Safety Information and Indications INDICATIONS

EYLEA® (aflibercept) Injection 2 mg (0.05 mL) is indicated for the treatment of patients with Neovascular (Wet) Age-related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR).

Please see the full Prescribing Information for EYLEA.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

The information provided in this site is intended for U.S. Doctors of Optometry.